Wolverine Stack: What It Is and Its U.S. Regulatory Status

What is the Wolverine Stack?

“Wolverine Stack” is an informal marketing name, not a scientific or regulatory term. It refers to a blend of two separate synthetic peptides: BPC-157 and TB-500. The nickname borrows from a comic book character, and it does not describe any tested or approved product.

BPC-157 is a 15-amino-acid peptide based on part of a protein found in human gastric juice. TB-500 is a synthetic peptide based on a region of thymosin beta-4, a naturally occurring protein that binds actin inside cells. Each compound has its own profile in our Peptide Guide.

What does research say?

Most published research on BPC-157 and on TB-500 has been done in laboratory and animal studies. The blend itself has not been evaluated as a combination in clinical trials, and its safety in people has not been established.

U.S. regulatory status

Current status: Not FDA-approved.

This means the FDA has not approved the Wolverine Stack as safe and effective for any medical use. No product containing it is an approved medicine in the United States.

Neither BPC-157 nor TB-500 is approved by the FDA on its own, and no combination of the two has been approved. Both are also prohibited in competitive sport under the World Anti-Doping Code.

Blends sold under nicknames can also vary in what they contain. Because they are not approved drugs, their contents and quality are not reviewed by the FDA.

Why Peptide Labs does not sell the Wolverine Stack

Peptide Labs does not sell this compound. This page is general information, not medical advice. Our Peptide Guide exists to explain what these compounds are and how they are regulated, not to supply them.

Anyone with questions about this blend should speak with a licensed healthcare provider, who can explain the current evidence and the legal status in plain terms.

Related reading

See the full list of compound profiles in the Peptide Guide.